eGenesis Company
Xenotransplant
Investors
Last Funding Type:
Series C
Last Funding Date:
2021
Headquarters:
USA
Industry:
Risk Mitigation
Investor Type:
Late Stage Venture
Estimated Revenue:
$10M to $50M
Total Funding:
$265.00
Investors Number:
27
Employee Number:
11-50
Founded Date:
2014